Received Apr 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
injection site pain; Arm pain; This non-serious case was reported by a other health professional via sales rep and described the occurrence of injection site pain in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site pain (Verbatim: injection site pain) and pain in arm (Verbatim: Arm pain). The outcome of the injection site pain and pain in arm were resolved. The reporter considered the injection site pain and pain in arm to be related to Shingrix. The company considered the injection site pain and pain in arm to be related to Shingrix. Additional Information: GSK Receipt Date: 23-APR-2025 The reporter was Respriatory Therapists. During group presentation, multiple audience members (HCPs) shared experience with receiving Shingrix including injection site pain and arm pain. Pain described as very painful and hesitation to receive second dose as a result.